https://www.selleckchem.com/pr....oducts/z-vad(oh)-fmk
cardioselective β1-blockers in a patient with asthma in a search of VigiBase. The reluctance to use cardioselective β1-blockers in people with asthma is not supported by this evidence. The aim of the study was to establish syndromic diagnoses in patients presenting with respiratory symptoms to healthcare facilities in Vietnam and to compare the diagnoses with facility-level clinical diagnoses and treatment decisions. A representative sample of patients aged ≥5 years, presenting with dyspnoea, cough, wheezing, and/or chest tightnes
Like
Comment
Share
